Currently, over 100 biosimilars are used in clinical practice and the total clinical experience with

Myrtelle shared clinical trial updates and future directions for Oligodendrocyte targeting AAVs at the 27th

Testing

A Q&A with Rick Layer, Vice President, Myrtelle’s Head of Pharmacology and Translational Science New